Nutex Health (NASDAQ:NUTX) Trading Up 8.2% – What’s Next?

Nutex Health Inc. (NASDAQ:NUTX) was up 8.2% on Thursday . The company traded as high as $185.33 and last traded at $186.65. Approximately 62,217 shares were traded during mid-day trading, a decline of 64% from the average session volume of 172,757 shares. The stock had previously closed at $172.45.

Analyst Upgrades and Downgrades

NUTX has been the topic of several recent research reports. B. Riley Financial started coverage on Nutex Health in a research report on Friday, June 26th. They issued a “buy” rating and a $290.00 price objective on the stock. Weiss Ratings raised shares of Nutex Health from a “hold (c)” rating to a “hold (c+)” rating in a research note on Tuesday, July 28th. Zacks Research upgraded shares of Nutex Health to a “hold” rating in a report on Monday, June 29th. Wall Street Zen downgraded shares of Nutex Health from a “strong-buy” rating to a “buy” rating in a report on Monday, July 20th. Finally, Lake Street Capital reissued a “buy” rating and issued a $310.00 price objective (up from $235.00) on shares of Nutex Health in a research report on Tuesday. Three research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $268.33.

Nutex Health Price Performance

The company has a 50 day moving average of $160.24 and a 200 day moving average of $129.58. The stock has a market capitalization of $1.29 billion, a price-to-earnings ratio of 7.41 and a beta of 0.24. The company has a quick ratio of 3.12, a current ratio of 3.14 and a debt-to-equity ratio of 0.66.

Institutional Investors Weigh In On Nutex Health

Several hedge funds have recently modified their holdings of NUTX. Kilter Group LLC purchased a new stake in Nutex Health in the second quarter valued at approximately $27,000. Allworth Financial LP purchased a new position in Nutex Health during the second quarter worth approximately $35,000. Islay Capital Management LLC acquired a new position in shares of Nutex Health in the 4th quarter valued at $34,000. BNP Paribas Financial Markets boosted its holdings in shares of Nutex Health by 966.7% in the 2nd quarter. BNP Paribas Financial Markets now owns 320 shares of the company’s stock valued at $40,000 after purchasing an additional 290 shares during the last quarter. Finally, Royal Bank of Canada raised its position in shares of Nutex Health by 752.4% in the 4th quarter. Royal Bank of Canada now owns 358 shares of the company’s stock worth $59,000 after buying an additional 316 shares during the period. 5.32% of the stock is owned by institutional investors and hedge funds.

Nutex Health Company Profile

Nutex Health, Inc (NASDAQ: NUTX) is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight‐loss services and behavioral health support. By combining in‐person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost‐effective treatment options outside traditional hospital settings.

The company’s urgent care network operates through both standalone and retail‐anchored centers, offering treatment for non‐life‐threatening injuries and illnesses, preventive screenings and basic primary care.